JP5057226B2 - Microchip for blood test and method of using the same - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a microchip capable of ensuring the accuracy and the reliability in measurement data obtained by inspection/analysis, since the presence of insoluble constituents, such as fats, and/or excess in globule constituents in whole blood samples can be detected by a series of operation of inspection and analysis, using the microchip. <P>SOLUTION: The microchip for inspecting blood has a plasma-separating section 102 for separating plasma constituents from a sample, containing total blood introduced into the microchip. The plasma-separating section 102 comprises a plasma storage section 110 for mainly storing plasma constituents after separation; and a globule storage section 120, that is connected to the bottom of the plasma storage section and mainly stores globule constituents after separation. The microchip for inspecting blood has an optical path adjustment means 130 for adjusting the optical path of irradiation light, is applied to the plasma-separating section so that the optical path passes the liquid surface of the plasma constituents after separation stored in the plasma storage section and the bottom of the plasma storage section. A utilization method of this microchip is also provided. <P>COPYRIGHT: (C)2009,JPO&amp;INPIT

Description

  The present invention relates to a microchip useful as a micro-TAS (Micro Total Analysis System) or the like that is suitably used for biochemical tests such as blood, chemical synthesis, and environmental analysis.

  In recent years, the importance of detecting, detecting or quantifying biological substances such as DNA (Deoxyribo Nucleic Acid), enzymes, antigens, antibodies, proteins, viruses and cells, and chemical substances in fields such as medicine, health, food, and drug discovery There have been proposed various biochips and microchemical chips (hereinafter collectively referred to as microchips) that can be easily measured.

  The microchip has a fluid circuit therein, and the fluid circuit contains, for example, a liquid reagent for processing a sample (blood or the like) to be tested or analyzed, or for reacting with the sample. Liquid reagent holding unit to be held, sample (or a specific component in the sample) and a measuring unit for measuring the liquid reagent, mixing unit for mixing the sample (or a specific component in the sample) and the liquid reagent, analysis and / or liquid mixture Alternatively, it is mainly composed of each part such as a detection part for inspection and a fine flow path (for example, a width of about several hundred μm) that appropriately connects these parts.

  A microchip having such a fluid circuit can perform a series of experiments and analysis operations performed in a laboratory in a chip of several centimeters square and several millimeters in thickness. It has many advantages such as low cost, high reaction speed, high throughput testing, and the ability to obtain test results immediately at the site where the sample was taken, suitable for biochemical testing such as blood testing It is used for.

  In a microchip for blood tests, since various tests are often performed using plasma components in whole blood, the microchip fluid circuit normally removes blood cells from the whole blood introduced into the fluid circuit. A plasma separation unit for extracting and separating plasma components is provided. However, for example, when examining blood collected from a person suffering from or having symptoms of hyperlipidemia, the separated plasma component contains a component that is insoluble in plasma components such as fat, Insoluble components may interfere with precise examination and analysis of plasma components. In addition, since the test subject has hyperhematocritemia etc., when the blood cell volume in the whole blood sample is larger than usual, the blood plasma component may be mixed in the separated plasma component, Also in this case, there is a risk that precise examination and analysis of plasma components may be hindered. That is, when the liquid mixture introduced into the detection unit contains an insoluble component such as fat or a blood cell component, when the characteristic component in the mixture is detected by optical measurement, the insoluble component and / or the blood cell component Due to the presence, the light irradiated to the detection unit is obstructed, and there is a problem that accurate measurement data cannot be obtained. In addition, there is also a problem that accurate measurement data cannot be obtained because components in blood cells are mixed into plasma by hemolysis. As long as it is not known whether the separated plasma component contains insoluble components or blood cell components, even if the obtained measurement data is correct, the measurement data should be guaranteed to be “correct”. In addition, even if erroneous measurement data is obtained due to the influence of insoluble components or blood cell components, it cannot be determined whether or not the measurement data is “incorrect”.

  Therefore, if it is possible to know the presence of insoluble components such as fat in the whole blood sample and component abnormalities such as whether the whole blood sample is excessively bloody, the reliability of the test / analysis data for the mixed solution can be improved. . And, if the microchip itself has the function of judging the presence of such insoluble components and the presence or absence of excessive blood cells, it is possible to judge component abnormalities and test / analyze plasma components in one operation. Is extremely preferable.

In Patent Document 1, it is determined whether or not hyperlipidemia is caused by irradiating a sample (whole blood) introduced into a predetermined position of a blood analyzer with light and detecting the transmitted light. (Refer to claim 23 and FIG. 11 etc.). However, since this method measures whole blood that has not been subjected to component separation, the detection sensitivity is low, and it is considered that the validity of determining whether or not hyperlipidemia is very low.
US Pat. No. 5590052

  The present invention has been made to solve the above-mentioned problems, and its purpose is to examine the presence of insoluble components such as fat and / or excessive blood cell components in a whole blood sample by using a microchip. It is an object of the present invention to provide a microchip that can be detected in a series of operations and thus can guarantee the accuracy and reliability of measurement data obtained by the inspection / analysis.

  The present invention includes a plasma separation unit for separating plasma components from a sample containing whole blood introduced into a microchip, and the plasma separation unit includes a plasma storage unit that mainly stores plasma components after separation; And a blood cell storage unit mainly connected to the blood cell component after separation, connected to the bottom of the plasma storage unit, and the optical path of the irradiation light irradiated to the plasma separation unit is stored in the plasma storage unit A blood test microchip having an optical path adjusting means for adjusting so as to pass through the liquid surface of the plasma component after separation and the bottom of the plasma container.

  In the microchip for blood test according to the present invention, the plasma separation unit includes a first mirror as an optical path adjusting unit, and the first mirror is near the liquid surface of the plasma component after separation stored in the plasma storage unit or It is preferable to be disposed in the vicinity of the bottom of the plasma storage part, and more preferably in the vicinity of the liquid surface of the separated plasma component stored in the plasma storage part.

  Moreover, it is preferable that a plasma separation part is further provided with the 2nd mirror for changing the optical path of the light which passed the inside of the plasma component after the separation accommodated in a plasma accommodating part. The second mirror is disposed on the side where the first mirror is not disposed, either near the liquid surface of the plasma component after separation or near the bottom of the plasma container.

  Preferably, the irradiation light irradiated to the plasma separation unit is guided to the light source position of the irradiation light or the vicinity thereof via the first mirror and the second mirror.

  The optical path of the light whose optical path is adjusted by the optical path adjusting means is preferably substantially parallel to the surface of the microchip. Moreover, it is preferable that the optical path of the irradiation light irradiated to the plasma separation part is substantially perpendicular to the microchip surface.

  In the microchip for blood test of the present invention, the plasma storage part may have a protrusion formed on the side surface thereof from at least the liquid surface position of the plasma component after separation to the bottom of the plasma storage part. In this case, the optical path of the irradiation light applied to the plasma separation unit is adjusted by the optical path adjusting means so as to pass through the liquid surface of the separated plasma component accommodated in the projection and the bottom of the projection. It is preferable.

  Further, in the microchip for blood test of the present invention, the plasma container has a first protrusion formed on the side surface of the plasma component on the side surface and a second part formed on the bottom of the plasma container. Or an optical path for adjusting the optical path of the irradiation light applied to the plasma separator to pass through the first protrusion and / or the second protrusion. It is good also as a structure which has an adjustment means. Preferably, the optical path of the irradiation light applied to the plasma separation unit is such that the liquid surface of the plasma component after separation and / or the bottom of the second projection is accommodated in the first projection by the optical path adjusting means. It is adjusted to pass.

Moreover, this invention provides the usage method of the above-mentioned microchip for blood tests including the following processes.
(1) A step of introducing a sample into the plasma separation unit by applying centrifugal force to the microchip,
(2) a step of separating plasma components and blood cell components in the sample by applying centrifugal force to the microchip;
(3) irradiating light to the optical path adjusting means to pass through the plasma containing part containing the separated plasma component, and
(4) A step of detecting light emitted from the plasma container.

  According to the present invention, it is possible to detect the presence of insoluble components such as fat in a whole blood sample and component abnormality whether the whole blood sample is excessive in blood cells. Therefore, the measurement obtained by the inspection / analysis using the microchip. Data accuracy and reliability can be guaranteed. In particular, in the present invention, since a component abnormality can be detected in a series of operations for inspection and analysis using the microchip, it is extremely efficient as compared with the case of using a separate analyzer. .

  The present invention relates to a microchip for blood test that includes a part for detecting a component abnormality in the presence of insoluble components such as fat in a whole blood sample and whether or not the whole blood sample has excessive blood cells in its fluid circuit. is there. The size of the microchip of the present invention is not particularly limited, but can be, for example, about several cm in length and width and about several mm in thickness. The microchip for blood test of the present invention is typically used by being mounted on a device capable of applying centrifugal force thereto. That is, by applying a centrifugal force in an appropriate direction to the microchip, the plasma component is taken out from the whole blood sample, and then the plasma component and the liquid reagent are weighed, mixed, and the like. The specific component in the inside is detected.

  The fluid circuit formed inside the microchip for blood test according to the present invention is not particularly limited, but typically, a plasma separation unit that obtains a plasma component by removing blood cells and the like from a whole blood sample, Liquid reagent holding unit for holding a liquid reagent, each measuring unit for measuring the liquid reagent and the extracted plasma component, a mixing unit for mixing the measured liquid reagent and the plasma component, and the obtained mixing A detection unit for inspecting and analyzing the liquid is provided. Other parts are provided as necessary. Each part may be two or more in one microchip. In the present invention, the plasma separation unit is configured to detect an abnormal component of the whole blood sample described above.

  Each of the above components constituting the fluid circuit can sequentially perform measurement of plasma components and liquid reagents, mixing of the plasma components and liquid reagents, introduction of the mixed solution into the detection unit, etc., by applying an external centrifugal force. As described above, they are arranged at appropriate positions and are connected via a fine flow path (hereinafter sometimes simply referred to as a flow path). The detection / analysis (for example, detection of a specific component in the mixture) of the liquid mixture in the detection unit is usually performed by, for example, detecting the intensity of emitted light by irradiating the detection unit with light. The measurement is performed by optical measurement such as measuring an absorption spectrum of the mixed liquid held in the section, but is not limited thereto. Hereinafter, the present invention will be described in detail with reference to embodiments.

(First embodiment)
FIG. 1 is a schematic top view showing an example of a fluid circuit structure of a blood test microchip according to the present invention. The microchip shown in FIG. 1 has a sample tube mounting part 101 for incorporating a sample tube such as a capillary containing whole blood collected from a subject, blood cells are removed from the whole blood derived from the sample tube, and plasma is removed. A plasma separating unit 102 for obtaining components, a first measuring unit 103 for measuring separated plasma components, two liquid reagent holding units 104a and 104b for holding a liquid reagent, and a second measuring unit for measuring a liquid reagent 105a and the third measuring unit 105b, mixing units 106a to 106d for mixing the plasma component and the liquid reagent, and a detection unit 107 for performing inspection and analysis on the obtained mixed solution. The numbers of liquid reagent holding units and mixing units are not limited to the numbers shown in FIG.

  FIG. 2 is an enlarged schematic top view showing the plasma separation unit 102 in the microchip of FIG. As shown in FIG. 2, the plasma separation unit 102 includes a plasma storage unit 110 and a blood cell storage unit 120. The plasma storage unit 110 is a part that stores a layer mainly composed of plasma components after the separation of the components of the whole blood sample in the plasma separation unit 102, and the blood cell storage unit 120 is the main part after the component separation. This is a site that accommodates a blood cell layer. One end of the blood cell storage unit 120 is connected to the bottom 110 a of the plasma storage unit 110. Further, the other end of the blood cell storage unit 120 is connected to a waste liquid reservoir (not shown in FIG. 1) (the waste liquid reservoir 108 in FIG. 1) via the flow path 121. Furthermore, a first mirror 130 as an optical path adjusting means is installed in the upper region of the plasma storage unit 110, more specifically, near the liquid surface upper part of the plasma component after component separation. A second mirror 140 is installed outside the 110 and in the vicinity of the bottom 110a of the plasma container so as to face the first mirror 130.

  According to the microchip of this embodiment having such a structure, for example, the presence of an insoluble component such as fat in a whole blood sample or a component abnormality whether the whole blood sample is excessive in blood cells can be detected as follows, for example. Can do. This will be described with reference to FIG. FIG. 3 is a schematic top view showing a state after the whole blood sample is introduced into the plasma separation unit 102 shown in FIG. 2 and centrifuged (component separation). First, a whole blood sample is introduced into the plasma separation unit 102 by applying centrifugal force to the microchip. Next, a centrifugal force is further applied to centrifuge the whole blood sample to separate it into a plasma component 210 and a blood cell component 220. At this time, when an insoluble component that is insoluble in plasma components such as fat is present in the whole blood sample, such as the whole blood sample is derived from a hyperlipidemic patient, the plasma component stored in the plasma storage unit 110 A layer (thin film) of the suspended matter 230 made of the insoluble component is formed on the liquid surface 210. In addition, when the whole blood sample is derived from a patient with hyperhematocritemia and contains a lot of blood cell components, the blood cell component 220 cannot be stored in the blood cell storage unit 120 and overflows to the plasma storage unit 110. .

  After the whole blood sample is centrifuged, the first mirror 130 is irradiated with light from an angle substantially perpendicular to the surface of the microchip, for example (the arrow in FIG. 3 indicates the optical path of the irradiation light). The first mirror 130 is configured to totally reflect incident light (for example, has a mirror surface with an inclination of about 45 ° with respect to the microchip surface), and the first mirror 130. Is incident on the liquid surface of the plasma component 210 housed in the plasma container 110 (that is, the layer of the suspended matter 230 formed on the liquid surface) and the optical path passing through the bottom 110a of the plasma container. And passes through the plasma component 210 accommodated in the plasma accommodating part 110.

  4 is a schematic cross-sectional view of the plasma separation unit shown in FIG. 2, FIG. 4 (a) is a cross-sectional view taken along line II, and FIG. 2 (b) is a cross-sectional view taken along line II-II. FIG. As shown in FIG. 4, the first mirror 130 is not particularly limited. For example, the first mirror 130 may have a configuration in which a triangular prism-like protrusion is provided on the inner ceiling surface of one substrate constituting the microchip. The protrusion (first mirror) has a total reflection mirror having an inclination of, for example, about 45 ° with respect to the microchip surface. With this configuration, it is possible to adjust the optical path of the light applied to the first mirror 130 to the optical path passing through the liquid surface of the plasma component 210 accommodated in the plasma accommodating part 110 and the bottom part 110a of the plasma accommodating part. In addition, the optical path of the light emitted from the liquid surface of the plasma component 210 in the plasma container 110 can be adjusted to the light source position or the vicinity thereof (see the arrow in FIG. 3).

  The light emitted from the bottom 110a of the plasma storage unit is changed in optical path by the second mirror 140, passes through the plasma component 210 stored in the plasma storage unit 110 again, and then is irradiated by the first mirror 130. It is guided to or near the light source position (the light source is not shown). As shown in FIGS. 2 and 3, the second mirror 140 has a V angle of about 90 ° so that the optical path of the light emitted from the plasma storage unit 110 can be changed by about 180 °. A total reflection mirror having a letter-shaped groove and having a mirror surface on the groove surface can be used. However, the shape of the total reflection mirror is not limited to a 90 ° V-shape.

  For example, the light guided to or near the light source position can be obtained by using, for example, a detector provided at the same position or a device in which the light source and the detector are integrated. The ratio between the intensity of the induced light and the intensity of the irradiated light is measured. In the state shown in FIG. 3, the irradiation light passes through the layer of the suspended matter 230 formed on the liquid surface of the plasma component 210 and the layer of the blood cell component 220 overflowing to the plasma accommodating part 110. Compared to the case where the layer of 230 and the layer of blood cell component 220 are not present, the light transmittance is reduced. That is, by detecting the light that has passed through the plasma container 110 and measuring the transmittance thereof, the whole blood sample has at least one component abnormality such as the presence of floating substances such as fat or excessive blood cell components. You can know what you are doing. On the other hand, when the decrease in the transmittance is not recognized (that is, the decrease in the transmittance is the same as when only the plasma component is allowed to pass through), it can be determined that there is no abnormality in the component. As described above, according to the microchip of the present embodiment, it is possible to detect the presence / absence of a component abnormality of the whole blood sample, so that the accuracy of the test / analysis result of the plasma component using the microchip is ensured. When it is detected that there is a component abnormality, it is possible to alert the subject that there is a doubt about the fact and the reliability of the test result.

  In addition, since the microchip of the present embodiment has an optical path adjusting means such as the first mirror 130, the irradiation light is emitted from the plasma component 210 after centrifugation stored in the plasma storage unit 110. It passes through the liquid surface (that is, the layer of the suspended matter 230 formed on the liquid surface) and the bottom 110a of the plasma container. This makes it possible to detect both abnormalities of the presence of suspended matters such as fat and excessive blood cell components simultaneously with a single light irradiation. In addition, suspended substances such as fat derived from hyperlipidemia generally float on the plasma component liquid surface as a very thin film, but even in such a case, light should pass in the above-mentioned direction. This facilitates the detection. In Patent Document 1 described above, light is irradiated perpendicularly to the surface of the blood analyzer. In this case, light is accurately irradiated to a suspended matter formed in a thin film shape. It is extremely difficult to detect the presence of a thin film.

  Furthermore, in the microchip of the present embodiment, the component abnormality can be detected after separating the components of the whole blood sample, and the component abnormality detection is performed by irradiating each separated component with light. Therefore, highly accurate detection is possible. On the other hand, in Patent Document 1 described above, whether or not hyperlipidemia is measured on whole blood that has not been subjected to component separation is considered to have extremely low measurement sensitivity. Whether there are excessive blood cells can be detected only after the components are separated.

  Here, the microchip of the first embodiment can be variously modified within a range not deviating from the effect of the present invention. For example, the second mirror 140 may be omitted. In this case, the detector is installed on the extension line of the optical path of the light emitted from the plasma container 110. However, the second mirror capable of changing the optical path of light by about 180 ° as shown in FIG. 2 is suitable when using a device in which a light source and a detector are integrated, and Since the plasma storage part 110 can be passed twice, it is preferable because a change in transmittance can be detected with high sensitivity.

  The second mirror 140 may have a configuration similar to that of the first mirror 130. When such a mirror is used as the second mirror, the light emitted from the plasma container 110 travels in a direction substantially perpendicular to the microchip surface without returning to the plasma container 110 again.

  In addition, the first mirror may be installed not at the upper region of the plasma container 110 (near the liquid surface of the plasma component) but at the place where the second mirror 140 is installed in FIG. In this case, the second mirror may be installed at the place where the first mirror 130 is installed in FIG. 2, or may be omitted in the same manner as described above.

  The optical path of the light whose optical path is adjusted by the first mirror 130 (that is, the light passing through the plasma component after centrifugation stored in the plasma storage unit 110) is typically relative to the microchip surface. However, the present invention is not limited to this, and at least the liquid level of the plasma component after centrifugation stored in the plasma storage unit 110, Any optical path that passes through the bottom 110a of the plasma container may be used. In addition, the incident angle of the irradiation light applied to the first mirror 130 can typically be substantially perpendicular to the microchip surface (including a case where it is completely perpendicular). Without being limited thereto, the light reflected by the first mirror 130 passes through the liquid surface of the plasma component after the centrifugation and the bottom 110a of the plasma container, so that the mirror surface of the first mirror 130 has a mirror surface. It is appropriately selected in consideration of the inclination angle and the like.

  The volume of the plasma container and the blood cell container is not particularly limited. The amount of the whole blood sample introduced into the microchip, and how much blood cells are excessive are judged as abnormal components. It is determined appropriately according to

  Next, an example of the operation method of the microchip of this embodiment shown in FIG. 1 will be described. The operation method described below is an example, and the present invention is not limited to this method. First, a sample tube from which a whole blood sample is collected is inserted into the sample tube mounting unit 101. Next, a centrifugal force is applied to the microchip in the leftward direction in FIG. 1 (hereinafter simply referred to as “leftward”; the same applies to the other directions below), and the whole blood sample in the sample tube is taken out. The whole blood sample is introduced into the plasma separator 102 by centrifugal force and centrifuged to separate it into a plasma component and a blood cell component. At this time, if the whole blood sample contains a suspended matter such as fat, the suspended matter is also separated to form a film on the liquid surface of the plasma component. Further, due to this downward centrifugal force, the liquid reagent X in the liquid reagent holding unit 104a is measured by the second measuring unit 105a. Next, the first mirror installed in the plasma separation unit 102 is irradiated with light, and the component abnormality is confirmed by the method described above.

  Next, the separated plasma component is introduced into the first measuring unit 103 by a centrifugal force directed to the right. At this time, the separated blood cell component moves to the waste liquid reservoir 108. The measured liquid reagent X moves to the mixing unit 106b, and the liquid reagent Y in the liquid reagent holding unit 104b is discharged from the liquid reagent holding unit 104b.

  Next, the measured plasma component and the liquid reagent X are mixed by the mixing unit 106a by the downward centrifugal force, and the liquid reagent Y is measured by the third measuring unit 105b. Next, a rightward, downward, and rightward centrifugal force is sequentially applied to cause the mixed solution to move back and forth between the mixing units 106a and 106b, thereby sufficiently mixing the mixed solution. Next, the mixed liquid composed of the liquid reagent X and the plasma component and the measured liquid reagent Y are mixed in the mixing unit 106c by upward centrifugal force. Next, leftward, upward, leftward, and upward centrifugal forces are sequentially applied, and the mixed liquid is mixed between the mixing portions 106c and 106d, thereby sufficiently mixing the mixed liquid. Finally, the mixed liquid in the mixing unit 106c is introduced into the detection unit 107 by the rightward centrifugal force, and the mixed liquid is inspected and analyzed using, for example, the optical method described above.

(Second Embodiment)
FIG. 5 is an enlarged schematic top view showing the plasma separation part of the microchip for blood test according to the second embodiment of the present invention. 6 is a cross-sectional view taken along line VV in FIG. Hereinafter, although the characteristic part of this embodiment is described, other than that is the same as that of 1st Embodiment. The microchip shown in FIG. 5 has a protruding portion 511 on the side surface of the plasma containing portion 510. The protrusion 511 is a part for allowing the light whose optical path is adjusted by the first mirror 530 to pass. That is, the first mirror 530 and the second mirror 540 are installed to face each other with the protruding portion 511 interposed therebetween. By providing such a protruding part in the plasma storage part 510, the first mirror and the second mirror can be arranged outside the plasma storage part.

  In the present embodiment, as shown in FIG. 6, as the first mirror 530 and the second mirror 540, for example, mirrors having a mirror surface with an inclination of about 45 ° with respect to the microchip surface are used. it can. Thereby, for example, the irradiation light incident on the first mirror 530 at an angle substantially perpendicular to the microchip surface is the liquid level of the plasma component 610 stored in the protrusion 511 (that is, on the liquid level). Then, the light path is adjusted again in a direction substantially perpendicular to the surface of the microchip, and the emitted light is detected by the detector.

  Here, the protrusion 511 may be formed at least from the liquid surface position in the protrusion of the plasma component after centrifugation to the bottom of the plasma container 510. When the sample introduced into the microchip is introduced into the plasma separation unit, a certain amount of sample is weighed, and the excess sample flows out into the waste liquid reservoir. Therefore, the liquid level position of the plasma component in the protrusion is inevitably determined by the sample measurement amount in the plasma separation unit. The width | variety (A in FIG. 5) of the protrusion part 511 can be about 3-15 mm, for example. Further, the protrusion height (B in FIG. 5) of the protrusion 511 is not particularly limited, and can be, for example, approximately the same as or greater than the width of the first mirror.

  According to the microchip of the present embodiment as described above, the same effect as in the first embodiment can be obtained.

  The microchip of this embodiment can be modified in the same manner as in the first embodiment. For example, the second mirror 540 is not necessarily provided. Other modifications are as described above.

(Third embodiment)
FIG. 7 is an enlarged schematic top view showing the plasma separation part of the microchip for blood test according to the third embodiment of the present invention. Hereinafter, although the characteristic part of this embodiment is described, it is the same as that of 1st or 2nd embodiment except it. The microchip shown in FIG. 7 has a first protrusion 711 and a second protrusion 712 on the side surface of the plasma storage part 710. These protrusions are portions for allowing the light whose optical path is adjusted by the first mirror 730 to pass. That is, the first mirror 730 and the second mirror 740 are installed so as to face each other with the first protrusion 711 and the second protrusion 712 interposed therebetween. As the 1st mirror 730 and the 2nd mirror 740, the thing similar to 2nd Embodiment can be used. The feature of this embodiment is that the protrusions are provided only at the liquid surface position of the plasma component stored in the plasma storage unit 710 and at the bottom of the plasma storage unit 710.

  In the present embodiment, the irradiation light incident on the first mirror 730 at an angle substantially perpendicular to the microchip surface, for example, is the liquid level of the plasma component 610 contained in the first protrusion 711 (ie, The light path is adjusted in a direction substantially perpendicular to the microchip surface again after passing through the bottom 712a of the suspended matter 830 formed on the liquid surface and the second protrusion 712, and the emitted light Is detected by the detector.

  Here, the width of the first protrusion 711 and the second protrusion 712 (C1 and C2 in FIG. 7) can be set to about 0.3 to 5 mm, for example. C1 and C2 may be the same value or different values. Further, the protrusion heights (D1 and D2 in FIG. 7) of the first protrusion 711 and the second protrusion 712 are not particularly limited, and are, for example, approximately the same as or the width of the first mirror. This can be done. D1 and D2 may be the same value or different values. Moreover, it is not always necessary to have both the first protrusion and the second protrusion, and only one of the protrusions may be provided.

  According to the microchip of the present embodiment as described above, the same effect as in the first embodiment can be obtained. Moreover, when it has only any one of the 1st protrusion part 711 and the 2nd protrusion part 712, it can be detected whether insoluble components, such as fat, or excessive blood cells are present.

  The embodiment disclosed this time should be considered as illustrative in all points and not restrictive. The scope of the present invention is defined by the terms of the claims, rather than the description above, and is intended to include any modifications within the scope and meaning equivalent to the terms of the claims.

It is a schematic top view which shows an example of the fluid circuit structure of the microchip for blood tests of 1st Embodiment in this invention. It is a schematic top view which expands and shows the plasma separation part in the microchip of FIG. It is a schematic top view which shows the state after a whole blood sample is introduce | transduced into the plasma separation part shown by FIG. 2, and it centrifuged. The arrow indicates the optical path of the irradiation light. It is a schematic sectional drawing of the plasma separation part shown by FIG. It is a schematic top view which expands and shows the plasma separation part of the microchip for blood tests of 2nd Embodiment in this invention. It is sectional drawing in the VV line of FIG. It is a schematic top view which expands and shows the plasma separation part of the microchip for blood tests of 3rd Embodiment in this invention.

Explanation of symbols

  DESCRIPTION OF SYMBOLS 101 Sample tube mounting part, 102 Plasma separation part, 103 1st measurement part, 104a, 104b Liquid reagent holding | maintenance part, 105a 2nd measurement part, 105b 3rd measurement part, 106a, 106b, 106c, 106d Mixing part , 107 Detection unit, 108 Waste liquid storage unit, 110, 510, 710 Plasma storage unit, 110a Bottom of plasma storage unit, 120, 520, 720 Blood cell storage unit, 121, 521, 721 Flow path, 130, 530, 730 First , 140, 540, 740 Second mirror, 210, 610, 810 Plasma component, 220, 620, 820 Blood cell component, 230, 630, 830 Suspended matter, 511 Protruding part, 511a Protruding part bottom part, 711 First , The second projection, 712a the bottom of the second projection.

Claims (10)

A plasma separation unit for separating plasma components from a sample containing whole blood introduced into a microchip,
The plasma separator is
A plasma containing part mainly containing the plasma component after separation, and a blood cell containing part mainly containing the separated blood cell component connected to the bottom of the plasma containing part,
The liquid surface of the plasma component after separation stored in the plasma storage unit so that the optical path of the irradiation light applied to the plasma separation unit is substantially parallel to the surface of the microchip, and the plasma a first mirror as an optical path adjusting means for adjusting so as to pass through the housing part bottom possess,
The first micro mirror is a blood test microchip disposed in either the vicinity of the liquid surface of the separated plasma component stored in the plasma storage unit or the vicinity of the bottom of the plasma storage unit . The blood test microchip according to claim 1 , wherein the first mirror is disposed in the vicinity of the liquid surface of the separated plasma component housed in the plasma container. The plasma separation unit further includes a second mirror for changing an optical path of light that has passed through the plasma component after separation stored in the plasma storage unit,
The second mirror is disposed on either the liquid surface vicinity of the plasma component after separation or the plasma container bottom portion vicinity, on the side where the first mirror is not disposed. The microchip for blood tests according to 1 or 2 . 4. The blood test according to claim 3 , wherein the irradiation light applied to the plasma separation unit is guided to the light source position of the irradiation light or the vicinity thereof via the first mirror and the second mirror. Microchip. The microchip for blood tests according to any one of claims 1 to 4 , wherein an optical path of irradiation light applied to the plasma separation unit is substantially perpendicular to a surface of the microchip. The blood plasma storage part according to any one of claims 1 to 5 , wherein the plasma storage part has a protruding part formed on a side surface thereof from at least a liquid surface position of the plasma component after separation to a bottom part of the plasma storage part. Microchip. The optical path of the irradiation light applied to the plasma separation unit is adjusted by the optical path adjusting means so as to pass through the liquid surface of the separated plasma component housed in the protrusion and the bottom of the protrusion. The microchip for blood tests according to claim 6 . The plasma container has, on its side surface, a first protrusion formed at the liquid surface position of the plasma component after separation and / or a second protrusion formed at the bottom of the plasma container. ,
The optical path of the illumination light irradiated to the plasma separating unit, having an optical path adjusting means for adjusting so as to pass through the first projections and / or the second protrusion, claim 1-5 The microchip for blood tests described in 1. The optical path of the irradiation light applied to the plasma separation part passes through the liquid surface of the plasma component after separation and / or the bottom of the second protrusion part accommodated in the first protrusion by the optical path adjusting means. The microchip for blood tests according to claim 8 , adjusted as described above. A method for using the microchip for blood test according to claim 1,
(1) introducing the sample into the plasma separation unit by applying centrifugal force to the microchip;
(2) separating a plasma component and a blood cell component in the sample by applying a centrifugal force to the microchip;
(3) irradiating the optical path adjusting means with light to pass through the plasma containing part containing the separated plasma component;
(4) detecting light emitted from the plasma container;
Of using a microchip for blood testing, comprising:

Images